PMC:7396557 / 85124-85262 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T889","span":{"begin":64,"end":69},"obj":"PR:000000134"},{"id":"T890","span":{"begin":71,"end":75},"obj":"PR:000001393"},{"id":"T891","span":{"begin":81,"end":85},"obj":"PR:000001395"},{"id":"T95323","span":{"begin":64,"end":69},"obj":"PR:000000134"},{"id":"T81429","span":{"begin":71,"end":75},"obj":"PR:000001393"},{"id":"T37285","span":{"begin":81,"end":85},"obj":"PR:000001395"}],"text":", the SFI treatment group had significantly decreased levels of TNF-α, IL-6, and IL-8 7 days after administration, indicating that SFI eff"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T811","span":{"begin":81,"end":85},"obj":"http://purl.obolibrary.org/obo/CLO_0053704"}],"text":", the SFI treatment group had significantly decreased levels of TNF-α, IL-6, and IL-8 7 days after administration, indicating that SFI eff"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T68753","span":{"begin":20,"end":25},"obj":"Chemical"},{"id":"T300","span":{"begin":71,"end":73},"obj":"Chemical"},{"id":"T84714","span":{"begin":81,"end":83},"obj":"Chemical"}],"attributes":[{"id":"A73151","pred":"chebi_id","subj":"T68753","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A54806","pred":"chebi_id","subj":"T300","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A74488","pred":"chebi_id","subj":"T300","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A83798","pred":"chebi_id","subj":"T84714","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A902","pred":"chebi_id","subj":"T84714","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":", the SFI treatment group had significantly decreased levels of TNF-α, IL-6, and IL-8 7 days after administration, indicating that SFI eff"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"2423","span":{"begin":64,"end":69},"obj":"Gene"},{"id":"2424","span":{"begin":71,"end":75},"obj":"Gene"},{"id":"2425","span":{"begin":81,"end":85},"obj":"Gene"}],"attributes":[{"id":"A2423","pred":"tao:has_database_id","subj":"2423","obj":"Gene:7124"},{"id":"A2424","pred":"tao:has_database_id","subj":"2424","obj":"Gene:3569"},{"id":"A2425","pred":"tao:has_database_id","subj":"2425","obj":"Gene:3576"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":", the SFI treatment group had significantly decreased levels of TNF-α, IL-6, and IL-8 7 days after administration, indicating that SFI eff"}